Atypical parkinsonism syndromes, such as dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration, are neurodegenerative diseases with complex clinical and pathological features. Heterogeneity in clinical presentations, possible secondary determinants as well as mimic syndromes pose a major challenge to accurately diagnose patients suffering from these devastating conditions. Over the last two decades, significant advancements in genomic technologies have provided us with increasing insights into the molecular pathogenesis of atypical parkinsonism and their intriguing relationships to related neurodegenerative diseases, fueling new hopes to incorporate molecular knowledge into our dia...
Up to 80% of Parkinson's disease patients develop dementia, but time to dementia varies widely from ...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...
Atypical parkinsonism syndromes, such as dementia with Lewy bodies, multiple system atrophy, progres...
Abstract: Atypical parkinsonism syndromes, such as dementia with Lewy bodies, multiple system atroph...
Although classic Parkinson disease is the disorder most commonly associated with the clinical featur...
peer reviewedFor several decades there has been a controversy on the contribution of genetic factors...
Parkinson disease (PD) is known as a common progressive neurodegenerative disease which is clinicall...
The role of genetics in the pathogenesis of Parkinson's disease has been subject to debate for decad...
Multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are uncommon multifactorial a...
The discovery of genes implicated in familial forms of Parkinson's disease (PD) has provided new ins...
Increased burdens of rare coding variants in genes related to lysosomal storage disease or mitochond...
Objective: To perform the genetic characterization of a cohort with familial parkinsonism and cognit...
Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progr...
Multiple system atrophy is considered a sporadic disease, but neuropathologically confirmed cases wi...
Up to 80% of Parkinson's disease patients develop dementia, but time to dementia varies widely from ...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...
Atypical parkinsonism syndromes, such as dementia with Lewy bodies, multiple system atrophy, progres...
Abstract: Atypical parkinsonism syndromes, such as dementia with Lewy bodies, multiple system atroph...
Although classic Parkinson disease is the disorder most commonly associated with the clinical featur...
peer reviewedFor several decades there has been a controversy on the contribution of genetic factors...
Parkinson disease (PD) is known as a common progressive neurodegenerative disease which is clinicall...
The role of genetics in the pathogenesis of Parkinson's disease has been subject to debate for decad...
Multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are uncommon multifactorial a...
The discovery of genes implicated in familial forms of Parkinson's disease (PD) has provided new ins...
Increased burdens of rare coding variants in genes related to lysosomal storage disease or mitochond...
Objective: To perform the genetic characterization of a cohort with familial parkinsonism and cognit...
Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progr...
Multiple system atrophy is considered a sporadic disease, but neuropathologically confirmed cases wi...
Up to 80% of Parkinson's disease patients develop dementia, but time to dementia varies widely from ...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...
Background: With advances in clinical genetic testing, associations between genetic neurodevelopment...